Author:
Pati Sarthak,Sharma Vaibhav,Aslam Heena,Thakur Siddhesh P.,Akbari Hamed,Mang Andreas,Subramanian Shashank,Biros George,Davatzikos Christos,Bakas Spyridon
Publisher
Springer International Publishing
Reference50 articles.
1. Ostrom, Q.T., Rubin, J.B., Lathia, J.D., Berens, M.E., Barnholtz-Sloan, J.S.: Females have the survival advantage in glioblastoma. Neuro Oncol. 20(4), 576 (2018)
2. Herrlinger, U., et al.: Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial. The lancet 393(10172), 678–688 (2019)
3. Hou, L.C., Veeravagu, A., Hsu, A.R., Victor, C.: Recurrent glioblastoma multiforme: a review of natural history and management options. Neurosurg. Focus 20(4), E3 (2006)
4. Akbari, H., et al.: Imaging surrogates of infiltration obtained via multiparametric imaging pattern analysis predict subsequent location of recurrence of glioblastoma. Neurosurgery 78(4), 572–580 (2016)
5. Fathi Kazerooni, A., et al.: Cancer imaging phenomics via CaPTk: multi-institutional prediction of progression-free survival and pattern of recurrence in glioblastoma. JCO Clin. Cancer Inf. 4, 234–244 (2020)
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献